Median salary
$190,000
per year · annualized USD
Typical range
$151.9k – $230.5k
25th–75th percentile
Disclosing pay
24.1%
715 of 2,965 roles
Live roles
2,965
open right now
Outside Sales Business Development Leader – West Coast
Hematologist Oncologist 100k SIGN ON BONUS San Diego CA
Global Chief Medical Officer
Chief Scientific Officer
VP, Medical Affairs
Sr. Medical Director/Executive Director, Early Clinical Development
Strategic Account Executive, Life Sciences
Strategic Client Partner, USA
| Company | Median | Roles |
|---|---|---|
BridgeBio Pharma
|
$182,500 | 105 |
Revolution Medicines
|
$237,500 | 104 |
Legend Biotech US
|
$147,206 | 49 |
Benchling
|
$193,125 | 36 |
| CP Compass Pathways | $205,000 | 22 |
| LS Lila Sciences | $164,667 | 20 |
Dyne Therapeutics
|
$218,000 | 19 |
Acadia Pharmaceuticals Inc.
|
$200,125 | 18 |
| Location | Median | Roles |
|---|---|---|
| San Francisco | $194,251 | 121 |
| New York | $185,000 | 60 |
| Boston | $174,305 | 35 |
| London | $102,500 | 6 |
See every Biotech Research role
Browse the live listings, or save this search and get alerted the moment a new one posts.
The median salary for Biotech Research roles is $190,000 per year. Most pay falls between $151,922 (25th percentile) and $230,475 (75th percentile), with the broader 10th–90th percentile band running from $110,000 to $274,500.
These figures are computed live from 2,965 active Biotech Research roles on JobsRadar, of which 715 (24.1%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid Biotech Research roles include Prendio - BioProcure, The Oncology Institute of Hope and Innovation, Legend Biotech US and Anthropic.
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.